When setup takes a week but the PO takes six months

In the last few weeks, three separate prospects reached out to us in what looked like sudden bursts of interest. One came right after closing a funding round. Another accelerated a call after months of sounding noncommittal. A third reappeared inbound after nearly a year of silence.

In all three cases, we asked some version of the same question: why the sudden urgency? The answers were surprisingly similar.

The team that just raised told us they'd been thinking about using Kaleidoscope for months but couldn't justify the switch internally. The new funding didn't create the need; it gave them means to act on it. The team that accelerated the call had an internal champion who'd been pushing to use Kaleidoscope for at least six or seven months prior to us meeting. And the team that went quiet for a year needed that time to get cross-functional buy-in.

None of this is unusual if you sell enterprise software to large organizations. Long cycles, multiple stakeholders, and internal politics are part of the process.

But these aren't true Enterprise deals.

These are early to mid-stage R&D companies. And yet, the buying process looks like it's for a much larger organization. That mismatch has consequences that go well beyond any individual deal. The most immediate consequence is DIY workarounds.

If the pain is real but a purchase feels hard to coordinate, the fallback is almost always some version of building it yourself. Teams default to spreadsheets, shared folders, internal tools, and manual workarounds. These can be started without waiting for anyone’s approval.

DIY in this space is not usually a sign that the problem is small. Rather, it's a sign that the buying process is disproportionately hard vis-a-vis the contract size. The person who wants the tool can't unilaterally buy it, and the effort required to build internal consensus is out of proportion with what the organization thinks it's spending on.

This points to something that is systematically undervalued in our market: how much a vendor can help build internal consensus during the buying process.

A lot of teams instinctively keep vendors at arm's length while they work through internal alignment. The assumption is understandable: if a vendor gets too involved, it starts to feel like a biased process. But, in practice, the smoothest and most aligned buying processes we've seen were the ones where the champion treated us less like a salesperson to manage, and more like a partner in the decision.

This doesn’t mean handing over the process, defaulting to everything the vendor says, or even necessarily choosing that vendor to work with in the end. It means using the vendor's pattern recognition: who to involve first, how to scope the initial workflow, what concerns different stakeholders will raise, where deals stall, what kind of rollout will survive contact with the organization.

When we look at the contracts that have gone best for us, the pattern is consistent. The champion brought us in early. There was backchanneling between meetings. We helped think through sequencing and stakeholder concerns. There was a clear shape to the process.

Weaker processes we’ve been involved in look entirely different: there were too many stakeholders, parallel conversations happening across the organization without any structure, and one champion doing all the translation work alone. All of this compounds into dramatically slower progress and a much lower hit rate in creating alignment. This, sadly, is still the default. The vendor gets brought in after the internal decision is mostly made, or not at all. And that has a consequence that goes beyond any individual deal.

If you're a small, focused team building software for R&D, you're already operating with constraints most other companies don’t have to deal with. To begin with, your target market is comparatively narrow. Then you layer on decision cycles that look like Enterprise sales, buyers who aren’t experienced software purchasers, and contract sizes that don't reflect the effort required to close them. Most good teams simply won't tolerate that for long. They either move upmarket to Pharma where the deal sizes justify the grind, or they leave the space entirely.

This is a big part of why so much R&D software feels underbuilt. It's not that nobody has tried. It's that the economics of selling into this market are brutal enough to drive out most of the teams capable of building something great. The ones that stay tend to be the ones that care about the space for reasons beyond the math (we happen to be one of those teams).

There isn’t a clean fix for that. But there is a more practical step: both sides, vendors and buyers, need to get better at the buying process. Champions need to bring vendors in earlier and vendors need to treat the buying process as part of the product. Although bringing the vendor in earlier doesn’t guarantee a better outcome, treating them as part of the process usually makes it easier to get to one quicker.

Kaleidoscope is a software platform for Life Science teams to robustly manage their R&D operations. With Kaleidoscope, teams can plan, orchestrate, and de-risk their programs with confidence, ensuring that they hit key milestones on time and on budget. By connecting teams, projects, decisions, actions, and underlying data in one spot, Kaleidoscope enables R&D teams to save months each year in their path to market.